RSS

Kazia Therapeutics

Ovarian cancer patients are losing out as funding and attention is focused on more prominent women’s diseases, says Australian oncology researcher, Dr Jim Coward, on World Ovarian Cancer Day (8 May). more

News

A Phase II clinical trial has begun in the US to evaluate a new drug, GDC-0084, that targets the signalling pathway implicated in almost all (90%) of glioblastoma multiforme brain cancer cases. more

News